FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

4538311000001101: Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17855101000001116 Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17855201000001111 Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) Is a Alfuzosin 5mg modified-release tablets true Inferred relationship Existential restriction modifier
Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) Has active ingredient Alfuzosin hydrochloride false Inferred relationship Existential restriction modifier
Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) Is a Xatral SR true Inferred relationship Existential restriction modifier
Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) Has specific active ingredient Alfuzosin hydrochloride true Inferred relationship Existential restriction modifier
Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) Has active ingredient Alfuzosin true Inferred relationship Existential restriction modifier
Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet Is pack of False Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier
Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet Has AMP True Xatral SR 5mg tablets (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start